Evonetix raises £9m for novel gene synthesis tech
Cambridge, UK-based Evonetix has raised £9 million to help fuel the advance of its technology designed to enable scalable and high-fidelity gene synthesis.
Read More
Tag: synthetic biology
NPL, Imperial College London launch new virtual lab
NPL and Imperial College London have unveiled a new £7 million virtual lab to help the UK’s synthetic biology industry enhance the manufacturing and adoption of new drugs, therapies and other products.
Read More
- Ipsen announces new data on Dysport in neurological disease
- PMGroup Worldwide Ltd welcomes MAD World Summit
- Argenx receives review from FDA for VYVGART in seronegative gMG
- Nuclera extends Series C funding to advance antibody engineering
- Cellistic launches new iPSC-based platforms to expand immuno-oncology therapies
